A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD

Reflecting the anti-inflammatory role of A20, its relative decrease during attacks might even start before the patient's first symptoms. Thus, longitudinal evaluation of A20 at (yet to identifiable) standardized time points might have prognostic implications. Serum A20 levels in pediatric patients with MOGAD may help to distinguish attacks from remission in monophasic disease courses. Consequently, A20 needs to be prospectively investigated in standardized multicentric longitudinal study designs, with a focus on diagnostic, prognostic, and therapeutic implications.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2025-08-18
DOI
https://doi.org/10.1212/nxi.0000000000200452
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD

Matthias Baumann, Mareike Schimmel, Steffen Leiz, Markus Breu et al.
Neurology Neuroimmunology & Neuroinflammation
Mitochondrial Function and Pathology
article

A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD

Matthias Baumann, Mareike Schimmel, Steffen Leiz, Markus Breu, Andrea Klein, Astrid Eisenkölbl, Shrishti Saxena, Michael Karenfort, Kevin M. Rostasy, Christian Lechner, Tanuja Chitnis, Markus Reindl, Eva‐Maria Wendel, Timothy B. Rooney, Martin Preisel, Mattia Rosso, Hrishikesh Lokhande
article en

Abstract

Reflecting the anti-inflammatory role of A20, its relative decrease during attacks might even start before the patient's first symptoms. Thus, longitudinal evaluation of A20 at (yet to identifiable) standardized time points might have prognostic implications. Serum A20 levels in pediatric patients with MOGAD may help to distinguish attacks from remission in monophasic disease courses. Consequently, A20 needs to be prospectively investigated in standardized multicentric longitudinal study designs, with a focus on diagnostic, prognostic, and therapeutic implications.

Neurology Neuroimmunology & NeuroinflammationVol. 12(5)
Johannes Kepler University of Linz (AT), Brigham and Women's Hospital (US), Harvard University (US), Innsbruck Medical University (AT), Alnylam Pharmaceuticals (United States) (US), Medical University of South Carolina (US), Witten/Herdecke University (DE), Paracelsus Medical University (AT), University Hospital of Bern (CH), University Hospital Augsburg (DE), Düsseldorf University Hospital (DE), Olgahospital (DE), Kepler Universitätsklinikum (AT), München Klinik (DE), University Children’s Hospital Bern (CH), Klinikum Stuttgart (DE), Heinrich Heine University Düsseldorf (DE), Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 81%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.